Abstract
Liquid chromatography–(tandem) mass spectrometry (LC–MS/MS) has revolutionized the detection assays used in doping control analysis over the last decade. New methods have enabled the determination of drugs that were formerly difficult to detect or undetectable at preceding sample concentrations, and complex and/or time-consuming procedures based on alternative chromatographic–mass spectrometric or immunochemical principles have been replaced by faster, more comprehensive and robust assays. A critical overview of the contributions of LC–MS(/MS) to sports drug testing is provided, including recent developments regarding low and high molecular weight drugs.
Similar content being viewed by others
References
Maurer HH (2004) Clin Chem Lab Med 42:1310–1324
Maurer HH, Peters FT (2005) Ther Drug Monit 27:686–688
Politi L, Groppi A, Polettini A (2005) J Anal Toxicol 29:1–14
Thevis M, Schänzer W (2005) Curr Org Chem 9:825–848
Thevis M, Schänzer W (2007) Mass Spectrom Rev 26:79–107
Thevis M, Schänzer W (2005) Curr Proteomics 2:191–208
World Anti-Doping Agency (2005) The 2006 prohibited list: international standard. World Anti-Doping Agency, Montreal, Canada. Accessed January 22, 2007. http://www.wada-ama.org/rtecontent/document/2006_LIST.pdf
Thevis M, Schänzer W (2005) J Am Soc Mass Spectrom 16:1660–1669
Thevis M, Opfermann G, Bommerich U, Schänzer W (2004) J Mass Spectrom 40:494–502
Deventer K, Eenoo PV, Delbeke FT (2006) Biomed Chromatogr 20:429–433
Leinonen A, Kuuranne T, Kotiaho T, Kostiainen R (2004) Steroids 69:101–109
Mazzarino M, Botre F (2006) Rapid Comm Mass Spectrom 20:3465–3476
Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y-C, Hatton CK (2004) Rapid Commun Mass Spectrom 18:1245–1249
Thevis M, Geyer H, Mareck U, Schänzer W (2005) J Mass Spectrom 40:955–962
Nielen MW, Bovee TF, van Engelen MC, Rutgers P, Hamers AR, van Rhijn JH, Hoogenboom LR (2006) Anal Chem 78:424–431
Chen F, Rodan GA, Schmidt A (2002) Zhonghua Nan Ke Xue 8:162–168
Chen J, Kim J, Dalton JT (2005) Mol Interv 5:173–188
Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD (2005) Exp Opin Ther Patents 15:1565–1585
Thevis M, Kamber M, Schänzer W (2006) Rapid Commun Mass Spectrom 20:870–876
Schänzer W, Geyer H, Fusshöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M (2006) Rapid Comm Mass Spectrom 20:2252–2258
Thevis M, Schebalkin T, Thomas A, Schänzer W (2005) Chromatographia 62:435–439
Thevis M, Fußhöller G, Geyer H, Mareck U, Sigmund G, Koch A, Thomas A, Schänzer W (2006) Chromatographia 64:441–446
Donike M (1970) Sportarzt und Sportmedizin 21:27–30
Donike M, Jaenicke L, Stratmann D, Hollmann W (1970) J Chromatogr 52:237–250
Hemmersbach P, de la Torre R (1996) J Chromatogr B 687:221–238
Maurer HH (1992) J Chromatogr 580:3–41
Donike M, Derenbach J (1976) Z Anal Chem 279:128–129
Deventer K, Van Eenoo P, Delbeke FT (2006) Rapid Commun Mass Spectrom 20:877–882
Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JM (2006) J Chromatogr B 836:111–115
Shpak AV, Appolonova SA, Semenov VA (2005) J Chromatogr Sci 43:11–21
Thevis M, Sigmund G, Schiffer AK, Schänzer W (2006) Eur J Mass Spectrom 12:129–136
Thevis M, Schänzer W (2005) J Chromatogr Sci 43:22–31
Thevis M, Opfermann G, Schänzer W (2004) Eur J Mass Spectrom 10:673–681
Gasthuys M, Alves S, Fenaille F, Tabet JC (2004) Anal Chem 76:6628–6634
Gasthuys M, Alves S, Tabet J (2005) Anal Chem 77:3372–3378
Goebel C, Alma C, Howe C, Kazlauskas R, Trout G (2005) J Chromatogr Sci 43:39–46
Thevis M, Ogorzalek Loo RR, Loo JA, Schänzer W (2003) Anal Chem 75:3287–3293
Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2005) Anal Chem 77:3579–3585
Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2006) Anal Chem 78:1897–1903
Gam LH, Tham SY, Latiff A (2003) J Chromatogr B 792:187–196
Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W (2006) Rapid Commun Mass Spectrom 20:3551–3556
Schumacher YO, Ashenden M (2004) Sports Med 34:141–150
Schumacher YO, Schmid A, Dinkelmann S, Berg A, Northoff H (2001) Int J Sports Med 22:566–571
Sonksen PH (2001) J Endocrinol 170:13–25
Wolfe RR (2005) Curr Opin Clin Nutr Metab Care 8:61–65
Wolfe RR (2000) Curr Opin Clin Nutr Metab Care 3:67–71
World Anti-Doping Agency (2004) WADA technical document TD2003IDCR. World Anti-Doping Agency, Montreal, Canada. Accessed January 22, 2007. http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf
Commission of the European Communities (2002) Commission decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Commission of the European Communities, Brussels, Belgium. Accessed January 22, 2007. http://eur-lex.europa.eu/LexUriServ/site/en/oj/2002/l_221/l_22120020817en00080036.pdf
US Department of Health and Human Services—Food and Drug Administration (2003) Guidance for industry: Mass spectrometry for confirmation of the identity of animal drug residues: final guidance. FDA, Washington, DC. Accessed January 22, 2007. http://www.fda.gov/cvm/Guidance/guide118.pdf#search=%22FDA%20mass%20spectrometry%20%22
Van Eenoo P, Delbeke FT (2004) Chromatographia 59:S39–S44
Stein SE, Heller DN (2006) J Am Soc Mass Spectrom 17:823–835
Mann M, Wilm M (1994) Anal Chem 66:4390–4399
Zhang Z, Sun S, Zhu X, Chang S, Liu X, Yu C, Bu D, Chen R (2006) BMC Bioinformatics 7:222
Eng JK, Mccormack AL, Yates JR (1994) J Am Soc Mass Spectrom 5:976–989
Yates JR 3rd (1998) Electrophoresis 19:893–900
Bethem R, Boison J, Gale J, Heller D, Lehotay S, Loo J, Musser S, Price P, Stein S (2003) J Am Soc Mass Spectrom 14:528–541
Wu CC, MacCoss MJ (2002) Curr Opin Mol Ther 4:242–250
Aebersold R, Mann M (2003) Nature 422:198–207
Ferguson PL, Smith RD (2003) Annu Rev Biophys Biomol Struct 32:399–424
MacCoss MJ (2005) Curr Opin Chem Biol 9:88–94
Chen EI, Hewel J, Felding-Habermann B, Yates JR 3rd (2006) Mol Cell Proteomics 5:53–56
Loo JA (2003) Adv Protein Chem 65:25–56
Loo JA, DeJohn DE, Du P, Stevenson TI, Ogorzalek Loo RR (1999) Med Res Rev 19:307–319
Thevis M, Loo JA, Ogorzalek Loo RR, Schänzer W (2007) Rapid Commun Mass Spectrom 21:297–304
Rivier L (2003) Anal Chim Acta 492:69–82
Acknowledgments
The authors thank the Manfred-Donike Institute for Doping Analysis for supporting the presented work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thevis, M., Schänzer, W. Current role of LC–MS(/MS) in doping control. Anal Bioanal Chem 388, 1351–1358 (2007). https://doi.org/10.1007/s00216-007-1131-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1131-4